Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Hepatitis A and NAT2[original query] |
|---|
| Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 2000 Nov 47 (5): 703-9. Yu M W, Pai C I, Yang S Y, Hsiao T J, Chang H C, Lin S M, Liaw Y F, Chen P J, Chen C |
| Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology (Baltimore, Md.) 2002 Apr 35 (4): 883-9. Huang Yi-Shin, Chern Herng-Der, Su Wei-Juin, Wu Jaw-Ching, Lai Shinn-Liang, Yang Shi-Yi, Chang Full-Young, Lee Shou-Do |
| N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease. Scandinavian journal of gastroenterology 2002 Jan 37 (1): 99-103. Agúndez J A G, Ladero J M, Olivera M, Lozano L, Fernández-Arquero M, de laConcha E G, Díaz-Rubio M, Benitez |
| Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. The American journal of gastroenterology 2003 Jun 98 (6): 1417-22. Huang Yi-Shin, Chern Herng-Der, Wu Jaw-Ching, Chao Yee, Huang Yi-Hsiang, Chang Full-Young, Lee Shou-Do |
| Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology (Baltimore, Md.) 2003 Apr 37 (4): 924-30. Huang Yi-Shin, Chern Herng-Der, Su Wei-Juin, Wu Jaw-Ching, Chang Shi-Chuan, Chiang Chi-Huei, Chang Full-Young, Lee Shou-Do |
| N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study. International journal of cancer. Journal international du cancer 2005 Jun 115 (2): 301-6. Gelatti Umberto, Covolo Loredana, Talamini Renato, Tagger Alessandro, Barbone Fabio, Martelli Claudia, Cremaschini Francesca, Franceschi Silvia, Ribero Maria Lisa, Garte Seymour, Nardi Giuseppe, Donadon Valter, Donato Frances |
| CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. European journal of clinical pharmacology 2006 Jun 62 (6): 423-9. Vuilleumier Nicolas, Rossier Michel F, Chiappe Alberto, Degoumois Florence, Dayer Pierre, Mermillod Bernadette, Nicod Laurent, Desmeules Jules, Hochstrasser Den |
| Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland) 2007 Nov 87 (6): 551-6. Cho Hyun-Jung, Koh Won-Jung, Ryu Yon-Ju, Ki Chang-Seok, Nam Myung-Hyun, Kim Jong-Won, Lee Soo-Yo |
| Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. European journal of clinical pharmacology 2008 Jul 64 (7): 673-81. Possuelo L G, Castelan J A, de Brito T C, Ribeiro A W, Cafrune P I, Picon P D, Santos A R, Teixeira R L F, Gregianini T S, Hutz M H, Rossetti M L R, Zaha |
| Determining the relation between N-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests. Tüberküloz ve toraks 2008 56 (1): 81-6. Bozok Cetinta? Vildan, Erer Onur Fevzi, Kosova Buket, Ozdemir Ilker, Topçuo?lu Nejat, Akto?u Serir, Ero?lu Zuh |
| Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. Pharmacogenomics 2009 Nov 10 (11): 1767-79. Kim Sang-Heon, Kim Sang-Hoon, Bahn Joon-Woo, Kim Yoon-Keun, Chang Yoon-Seok, Shin Eun-Soon, Kim Youn-Seup, Park Jae-Seuk, Kim Bo-Hyung, Jang In-Jin, Song Junghan, Kim Seung-Hyun, Park Hae-Sim, Min Kyung-Up, Jee Young-K |
| NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2010 May 14 (5): 622-6. Lee S-W, Chung L S-C, Huang H-H, Chuang T-Y, Liou Y-H, Wu L S |
| NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption. European journal of clinical pharmacology 2011 Feb 67 (2): 121-7. Kim Sang-Heon, Kim Sang-Hoon, Yoon Ho Joo, Shin Dong Ho, Park Sung Soo, Kim Youn-Seup, Park Jae-Seuk, Jee Young K |
| Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis. Pathologie-biologie 2012 Oct 60 (5): 324-30. Ben Mahmoud L, Ghozzi H, Kamoun A, Hakim A, Hachicha H, Hammami S, Sahnoun Z, Zalila N, Makni H, Zeghal |
| Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients. Memórias do Instituto Oswaldo Cruz 2011 Sep 106 (6): 716-24. Teixeira Raquel Lima de Figueiredo, Morato Renata Gomes, Cabello Pedro Hernan, Muniz Ligia Mayumi Kitada, Moreira Adriana da Silva Rezende, Kritski Afrânio Lineu, Mello Fernanda Carvalho Queiroz, Suffys Philip Noel, Miranda Antonio Basilio de, Santos Adalberto Rezen |
| Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis. Journal of gastroenterology and hepatology 2011 Feb 26 (2): 312-8. Bose Purabi Deka, Sarma Manash Pratim, Medhi Subhash, Das Bhudev Chandra, Husain Syed Akhtar, Kar Premash |
| Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia. PloS one 2014 9 (9): e106141. Yang Jen-Jia, Huang Chung-Hao, Liu Chun-Eng, Tang Hung-Jen, Yang Chia-Jui, Lee Yi-Chien, Lee Kuan-Yeh, Tsai Mao-Song, Lin Shu-Wen, Chen Yen-Hsu, Lu Po-Liang, Hung Chien-Chi |
| The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1. PloS one 2014 9 (1): e85905. Xiang Yang, Ma Long, Wu Weidong, Liu Wei, Li Yongguang, Zhu Xia, Wang Qian, Ma Jinfeng, Cao Mingqin, Wang Qian, Yao Xuemei, Yang Lei, Wubuli Atikaimu, Merle Corinne, Milligan Paul, Mao Ying, Gu Jiayi, Xin Xium |
| Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis. Journal of clinical and experimental hepatology 2019 4 9 (2): 200-206. Kar Premashis, Karna Rahul, Ruttala Rajesh, Arora Shilpa, Chakravarty Anita, Kumar Sure |
| Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil. Annals of hepatology 2019 Oct . Araujo-Mariz Carolline, Militão de Albuquerque Maria de Fátima P, Lopes Edmundo P, Ximenes Ricardo A A, Lacerda Heloísa R, Miranda-Filho Demócrito B, Lustosa-Martins Brena B, Pastor André Filipe P, Acioli-Santos Bartolom |
| Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment-A Study from Patients of Portuguese Health Centers. Journal of personalized medicine 2022 May 12 (5): . Cavaco Maria João, Alcobia Celeste, Oliveiros Bárbara, Mesquita Luís Alcides, Carvalho Aurora, Matos Fernando, Carvalho José Miguel, Villar Miguel, Duarte Raquel, Mendes João, Ribeiro Carolina, Cordeiro Carlos Robalo, Regateiro Fernando, Silva Henriqueta Coimb |
- Page last reviewed:Feb 1, 2024
- Content source: